Drug intelligence / Profile preview

Jiaoqishe gel patch

Development stage: Unknown
Lead developer: Changsha Tuoyang Medicine Technology
Administration: Topical, Transdermal

Overview

Jiaoqishe gel patch is a Traditional Chinese Medicine (TCM) topical therapeutic developed by Changsha Tuoyang Pharmaceutical Technology. It is specifically formulated for the treatment of pain in patients with knee osteoarthritis characterized by the "cold coagulation and blood stasis" pattern in TCM theory. The formulation is delivered via a gel patch (cataplasm) to provide localized relief. As of 2024, it is undergoing Phase 3 clinical trials in China to evaluate its efficacy and safety compared to placebo.

Other names: 椒七麝凝胶膏剂

Beyond the preview

Go deeper on Jiaoqishe gel patch.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jiaoqishe gel patch.

Explore the full profile